Almirall and IRB Barcelona team up to tackle skin disease
pharmaphorum
JANUARY 18, 2022
Almirall and IRB Barcelona (the Institute for Research in Biomedicine), will conduct research using molecular glue degraders, a new approach to the skin diseases under scrutiny. Researchers at Almirall have identified several proteins whose abnormal function is associated with inflammatory immune skin diseases.
52 
Let's personalize your content